Rekha Kumar1, Donna Ryan2. Show Affiliations » 1. Division of Endocrinology, Weill Cornell Medical College, New York, New York, USA. 2. Diabetes and Metabolism, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Abstract
Entities: Chemical
Mesh： See more » AnimalsAnti-Obesity Agents/adverse effectsAnti-Obesity Agents/therapeutic useBenzazepines/adverse effectsBenzazepines/therapeutic useEquivalence Trials as TopicHumansMaleMiceNeoplasms/chemically inducedNeoplasms/epidemiologyProduct Surveillance, PostmarketingRandomized Controlled Trials as TopicRisk FactorsSafety-Based Drug WithdrawalsTreatment OutcomeUnited States/epidemiologyUnited States Food and Drug Administration
Substances： See more » Anti-Obesity AgentsBenzazepineslorcaserin
Year: 2020 PMID： 32320522 DOI： 10.1002/oby.22789
Source DB: PubMed Journal: Obesity (Silver Spring) ISSN： 1930-7381 Impact factor: 5.002